| Name | Title | Contact Details |
|---|
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
CNH Industrial N.V. is a global manufacturer of agricultural and construction equipment, headquartered in Basildon, Essex, United Kingdom. The company has a rich history dating back to 1842 and was formed through the merger of Case Corporation and New Holland N.V. in 1999, later restructuring as CNH Industrial in 2013. With over 63,000 employees, CNH operates 67 manufacturing plants and 56 research and development centers across 180 countries. The company offers a wide range of products under well-known brands such as Case IH, New Holland Agriculture, and Case Construction Equipment. Their agricultural equipment includes tractors, combines, and precision farming technology, while their construction equipment features excavators, backhoe loaders, and dozers. CNH also provides financial services through CNH Industrial Capital, supporting customers with equipment financing and offering integrated engineering and aftermarket support. The company is committed to sustainable technologies, including precision agriculture and alternate fuel solutions.
Accelerant is a data-driven risk exchange connecting specialty insurance underwriters with risk capital providers. Founded in 2018 by a group of longtime insurance industry executives and technology experts, our vision is to rebuild the way risk is exchanged – so that it works better, for everyone. For the underwriters we call Members, we deliver a full service offering that includes insights and analytics, distribution management, operational resources, and stable underwriting capacity. Our approach frees our Members to focus on profitable underwriting while growing their businesses. Our portfolio presents attractive, validated, and diversified source of specialty insurance premium to our risk capital provider partners.